Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study.

Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study.